Diagnostic and therapeutic uses of inhaled nitric oxide in neonatal Ebstein’s anomaly
- 1 April 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (7), 906-908
- https://doi.org/10.1016/s0002-9149(03)00036-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Functional Pulmonary Atresia in Neonatal Marfan's Syndrome: Successful Treatment with Inhaled Nitric OxidePediatric Cardiology, 2001
- From functional pulmonary atresia to right ventricular restriction: Long term follow up of Uhl's anomalyInternational Journal of Cardiology, 1998
- Inhaled Nitric Oxide Therapy in a Critically Ill Neonate with Ebstein's AnomalyPediatric Cardiology, 1998
- Outcome in Cyanotic Neonates With Ebstein’s AnomalyThe American Journal of Cardiology, 1998
- Diagnostic use of inhaled nitric oxide after neonatal cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Outcome in neonates with Ebstein's anomalyJournal of the American College of Cardiology, 1992
- Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease.Heart, 1988
- Differentiation of functional and structural pulmonary atresia: Role of aortographyThe American Journal of Cardiology, 1978